Qualitative and Quantitative Estimation of Hydroquinone in Skin Whitening Cosmetics


Hydroquinone has been used for decades as a skin lightening agent. Its use in cosmetics has been banned as a result of skin problems including contact dermatitis and ochronosis. A total of 22 samples of different skin whitening cosmetics were collected from local market. They were analyzed by using thin layer chromatography and HPLC for qualitative and quantitative determination of their hydroquinone contents. The hydroquinone was extracted from samples by using 96% ethanol and was subjected to TLC analysis. Eleven out of 22 samples were found to contain hydroquinone. The HPLC analysis showed the concentration of hydroquinone ranged from 0.002% to 0.092% in the cosmetic samples.

Share and Cite:

S. Siddique, Z. Parveen, Z. Ali and M. Zaheer, "Qualitative and Quantitative Estimation of Hydroquinone in Skin Whitening Cosmetics," Journal of Cosmetics, Dermatological Sciences and Applications, Vol. 2 No. 3, 2012, pp. 224-228. doi: 10.4236/jcdsa.2012.23042.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] M. Seiberg, C. Paine, E. Sharlow, et al., “Inhibition of Mela-Nosomes Transfer Results in Skin Lightening,” Journal of Investigative Dermatology, Vol. 115, 2000, pp. 162-167. doi:10.1046/j.1523-1747.2000.00035.x
[2] J. V. Schaffer and J. L. Bolongia, “The Melanocortin-1 Receptor: Red Hair and Beyond,” Archives of Dermatology, Vol. 137, No. 11, 2001, pp. 1477-1485.
[3] H. S. Raper, “The Anaerobic Oxidases,” Physiological Reviews, Vol. 8, No. 2, 1928, pp. 245-282.
[4] S. S. Tai, C. G. Lin, M. H. Wu and T. S. Chang, “Evaluation of Depigmenting Activity by 8-Hydroxydaidzein in Mouse B16 Melanoma Cells and Human Volunteers,” International Journal of Molecular Sciences, Vol. 10, No. 10, 2009, pp. 4257-4266. doi:10.3390/ijms10104257
[5] H. Ando, M. Ichihashi and V. J. Hearing, “Role of the Ubiquitin Proteasome System in Regulating Skin Pigmentation,” International Journal of Molecular Sciences, Vol. 10, No. 10, 2009, pp. 4428-4434. doi:10.3390/ijms10104428
[6] G. E. Costin and V. J. Hearing, “Human Skin Pigmentation: Melanocytes Modulate Skin Color in Response to Stress,” FASEB Journal, Vol. 21, No. 4, 2007, pp. 976-994. doi:10.1096/fj.06-6649rev
[7] J. P. Ebanks, R. R. Wickett and R. E. Boissy, “Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration,” International Journal of Molecular Sciences, Vol. 10, No. 9, 2009, pp. 4066-4087. doi:10.3390/ijms10094066
[8] J. Lee, K. Jung, Y. S. Kim and D. Park, “Diosgenin Inhibits Melanogenesis through the Activation of Phosphatidylinositol-3-Kinase Pathway (PI3K) Signaling,” Life Sciences, Vol. 81, No. 3, 2007, pp. 249-254. doi:10.1016/j.lfs.2007.05.009
[9] T. S. Chang, “An Updated Review of Tyrosinase Inhibitors,” International Journal of Molecular Sciences, Vol. 10, No. 6, 2009, pp. 2440-2475. doi:10.3390/ijms10062440
[10] M. Mastore, L. Kohler and A. J. Nappi, “Production and Utilization of Hydrogen Peroxide Associated with Melanogenesis and Tyrosinase-Mediated Oxidations of DOPA and Dopamine,” FEBS Journal, Vol. 272, No. 10, 2005, pp. 2407-2415. doi:10.1111/j.1742-4658.2005.04661.x
[11] N. Smit, J. Vicanova and S. Pavel, “The Hunt for Natural Skin Whitening Agents,” International Journal of Molecular Sciences, Vol. 10, No. 12, 2009, pp. 5326-5349. doi:10.3390/ijms10125326
[12] R. Halaban, R. S. Patton, E. Cheng, S. Svedine, E. S. Trombetta, M. L. Wahl, S. Ariyan and D. N. Hebert, “Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway,” The Journal of Biological Chemistry, Vol. 277, No. 17, 2002, pp. 14821-14828.
[13] S. H. Hamed, P. Sriwiiyanont, R. R. Wickett and R. Boissy, “Effect of Deoxyarbutin on Melanogenesis: In Vivo Comparison with Other Melanogenesis Inhibitor,” Journal of Cosmetic Science, Vol. 55, No. 1, 2004, pp. 118-119.
[14] S. B. Adebajo, “An Epidermiological Survey of the Use of Cosmetic Skin Lightening Cosmetics among Traders in Lagos, Nigeria,” West African Journal of Medicine, Vol. 21, No. 1, 2002, pp. 51-55.
[15] N. Hardwick, et al., “Exogenous Ochronosis: An Epidermiological Study,” British Journal of Dermatology, Vol. 120, No. 2, 1989, pp. 229-238. doi:10.1111/j.1365-2133.1989.tb07787.x
[16] Twenty Fourth Directive 2000/6/EG Publication nr L056. European Union, 2000.
[17] Food and Drug Administration, “Skin Bleaching Drug Products for Over-the-Counter Human Use; Proposed Rule,” US Department of Health and Human Services, 29 August 2006.
[18] Federal Register, “Proposed Rules,” Vol. 71, No. 167, 2006, pp. 51146-51155.
[19] E. Stahal, “Thin Layer Chromatography,” George Allen and Unwin Limited, London, 1969.
[20] M. W. Akhtar, N. Kausar, M. N. Nawazish and Z. Hussain,” Pakistan Journal of Biological Sciences, Vol. 16, No. 2, 1981, p. 71.
[21] V. M. Veralla Rowell, V. Verallo, K. Graupe, L. Lopez- Villafuerte and M. Garcia-Lopez, “Double-Blind Comparison of Azelaic Acid and Hydroquinone in the Treatment of Melasma,” Acta Dermato-Venereological Supplementum (Stocckh), Vol. 143, 1981, pp. 58-61.
[22] K. B. Penny, C. J. Smith and J. C. Allen, “Depigmenting Action of Hydroquinone Depends on Disruption of Fundamental Cell Processes,” Journal of Investigative Dermatology, Vol. 82, 1984, pp. 308-310. doi:10.1111/1523-1747.ep12260588
[23] H. Jiang and T. Yan, “Determination of Hydroquinone in Cosmetics by GC-MS,” Weishing Yanjiu, Vol. 30, No. 1, 2001, p. 22.
[24] L. Cheng-Hui, et al., “Determination of Hydroquinone in Cosmetic Emulsion Using Microdialysis Sampling Coupled with HPLC,” Journal of Pharmaceutical & Biomedical Analysis, Vol. 38, No. 3, 2005, pp. 414-419.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.